Alan Reznik, MD
Sports Medicine · Hamden, CTNPI 1275539785
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $7,632 of the $8,547 with a category attached, or 89.3%. Innovative Medical Products, Inc. accounts for 89.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,848 and has fallen 52.7% since, to $874 in 2025.
Across 54 payments — averaging $158.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Innovative Medical Products, Inc.$8K
- Smith+Nephew$436
- Johnson & Johnson$141
- Vericel Corporation$115
- AbbVie$92
- Ferring Pharmaceuticals Inc.$69
- plus $64 from 2 others
What the payments were for
- Royalty or licence$7,63289%
- Food & beverage$89410%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Innovative Medical Products, Inc. | 28 | $7,632 |
| Smith+Nephew | 5 | $436 |
| Johnson & Johnson | 7 | $141 |
| Vericel Corporation | 5 | $115 |
| AbbVie | 1 | $92 |
| Ferring Pharmaceuticals Inc. | 4 | $69 |
| Amgen | 3 | $46 |
| Medartis Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,547 in reported general payments places this provider in the 70th percentile of 65 sports medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nabumetone | 241 | $1,543 |
| Celecoxib | 37 | $363 |
| Meloxicam | 77 | $202 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $195 |
| Cyclobenzaprine Hcl | 36 | $128 |
| Ciprofloxacin Hcl | 13 | $45 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Hamden
- John KelleyHamden$2K
- Patrick RuweHamden$332
- Richard DianaHamden$237
- David CohenHamden$179
- Augustus MazzoccaFarmington$1M
- Michael KaplanMiddlebury$385K
- Robert ArcieroFarmington$269K
- Karen SuttonStamford$245K
- Michael KuhnMiddletown$201K
- Katherine CoynerFarmington$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.